This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
insurance: Archive
4 Stocks to Watch From the Thriving Insurance Brokerage Industry
by Sushmita Sarker
Zacks Insurance Brokerage players like BRO, MMC, WTW and AON are likely to benefit from increased demand for insurance products, strategic acquisitions and the adoption of technology.
insurance
Zacks.com featured highlights include Hamilton Insurance, Macy's, Cognizant Technology Solutions, PCB Bancorp and PRA
by Zacks Equity Research
HG, M, CTSH, PCB and PRAA stand out for low price-to-sales ratios paired with steady momentum and firm-specific growth drivers.
computers finance insurance retail
LMND Surges 97% Year to Date: How Should You Play the Stock?
by Tanuka De
Lemonade surges 96.7% YTD, fueled by AI-driven growth and expanding insurance lines, but is it too pricey to buy now?
insurance
Zacks Industry Outlook Highlights Aflac, Unum Group, Globe Life and Trupanion
by Zacks Equity Research
Aflac, Unum, Globe Life and Trupanion stand out as insurers navigating pricing pressure and rising medical costs with disciplined underwriting and tech-driven efficiency.
insurance medical
5 Undervalued Stocks With Low Price-to-Sales Ratios & Strong Momentum
by Rajani Lohia
Low price-to-sales values spotlight HG, M, CTSH, PCB and PRAA as potential bargains, backed by solid fundamentals and momentum.
computers finance insurance retail
Bear of the Day: Molina Healthcare (MOH)
by Bryan Hayes
The company faces escalating operational and financial pressures that threaten its outlook.
earnings hmo insurance investing medical
Marsh & McLennan Unit Expands in Hawai'i With Three Brokerage Buys
by Zacks Equity Research
MMC expands its insurance solutions suite and presence in Hawai'i as Marsh McLennan Agency acquires three of the state's local insurance brokerages.
insurance
4 Accident & Health Insurers to Watch Amid Rising Medical Costs
by Tanuka De
Accident and Health Insurance stocks like AFL, UNM, GL and TRUP are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
insurance
Is UnitedHealth's Valuation Dip & Divestment Diet a Real Buy Window?
by Kaibalya Pravo Dey
UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.
healthcare hmo insurance insurance-premium medical
Heritage Insurance Skyrockets 136% YTD: Time to Buy the Stock?
by Zacks Equity Research
HRTG stock surges 136% YTD, fueled by strong underwriting, pricing discipline, and reinsurance-driven margin gains.
insurance